Silvana Spinelli, co-founder and CSO of Kresko RNAtech, was featured in La Capital, one of Argentina's leading newspapers, in an article on the BCR Agtech Forum held at the Bolsa de Comercio de Rosario.
At the forum, Silvana took part in the panel "Digital Biology: How AI Is Accelerating Bioproduct Development", on how artificial intelligence is transforming the way new biological solutions are discovered, developed and brought to market.
AI at the core of Kresko
Kresko has been built around this idea from the start. Our proprietary Serkanto-AI platform combines machine learning, deep learning and RNA biology to explore thousands of biological sequences and identify promising bioactive molecules from natural sources.
Research that once took years can now take months.
Work that started with milk-derived RNA now spans thousands of plant species.
Large volumes of biological data are becoming an engine for developing the next generation of functional ingredients.
The open challenge
As Silvana pointed out, AI is accelerating discovery much faster than regulatory frameworks are evolving. The goal is not just to generate more data, but to turn it into real products that improve people's lives.

